Benzinga - Thu, 25 Feb 2021 10:55:38 -0400
Benzinga - Thu, 11 Feb 2021 08:26:22 -0400
Benzinga - Wed, 10 Feb 2021 11:23:13 -0400
Benzinga - Wed, 10 Feb 2021 10:26:49 -0400
Benzinga - Wed, 10 Feb 2021 08:34:42 -0400
Benzinga - Tue, 09 Feb 2021 13:54:24 -0400
Benzinga - Tue, 09 Feb 2021 10:02:00 -0400
Benzinga - Tue, 09 Feb 2021 09:09:03 -0400
Benzinga - Mon, 08 Feb 2021 11:34:01 -0400
Benzinga - Mon, 08 Feb 2021 10:17:21 -0400
Benzinga - Fri, 05 Feb 2021 16:38:19 -0400
Benzinga - Fri, 05 Feb 2021 10:01:05 -0400
Benzinga - Thu, 04 Feb 2021 14:17:36 -0400
Benzinga - Thu, 04 Feb 2021 10:32:37 -0400
Benzinga - Thu, 04 Feb 2021 09:50:23 -0400
load more
Sector: Health Care.Industry: Biotechnology
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-05
REV
Q4 2020Est.ActualSurprise
EPS0.9901.620 0.6300
REV54.090M69.990M15.900M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LGNDLigand Pharmaceuticals2.64%2.5B

Ligand Pharmaceuticals Company Questions & Answers

Q

How do I buy Ligand Pharmaceuticals (LGND) stock?

A

You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ligand Pharmaceuticals's (LGND) main competitors?

A

Other companies in Ligand Pharmaceuticals’s space includes: Cerevel Therapeutics Hldg (NASDAQ:CERE), OPKO Health (NASDAQ:OPK) and Inovio Pharmaceuticals (NASDAQ:INO).

Q

What is the target price for Ligand Pharmaceuticals?

A

The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by Barclays on 2021-02-04. The analyst firm set a price target for 198.00 expecting LGND to rise to within 12 months (a possible 31.82% upside). 9 analyst firms have reported ratings in the last year.

Q

How much is Ligand Pharmaceuticals (LGND) stock ?

A

The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $150.21 last updated Thu Feb 25 2021 21:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Ligand Pharmaceuticals (LGND) dividend?

A

There are no upcoming dividends for Ligand Pharmaceuticals. The last dividend paid out to investors was $NaN on 2007-04-03.

Q

When is Ligand Pharmaceuticals (NASDAQ:LGND) reporting earnings?

A
Ligand Pharmaceuticals’s Q1 earnings are confirmed after-market from now on May 5, 2021.
Q

When is the upcoming split for LGND?

A

There is no upcoming split for Ligand Pharmaceuticals.